Literature DB >> 8753863

Identification of C to T mutation at position -236 bp in the human NRAMP1 gene promoter.

L A Lewis1, T C Victor, E G Helden, J M Blackwell, F da Silva-Tatley, S Tullett, M Ehlers, N Beyers, P R Donald, P D van Helden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8753863     DOI： 10.1007/bf02602562

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  12 in total

1.  Identification of a highly polymorphic length variant in the 3'UTR of NRAMP1.

Authors:  N T Buu; M Cellier; P Gros; E Schurr
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

2.  The use of a geographical information system (GIS) to evaluate the distribution of tuberculosis in a high-incidence community.

Authors:  N Beyers; R P Gie; H L Zietsman; M Kunneke; J Hauman; M Tatley; P R Donald
Journal:  S Afr Med J       Date:  1996-01

3.  The macrophage resistance gene Lsh/Ity/Bcg.

Authors:  J M Blackwell
Journal:  Res Immunol       Date:  1989-10

4.  Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg.

Authors:  S M Vidal; D Malo; K Vogan; E Skamene; P Gros
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

5.  Genetic and physical mapping of 2q35 in the region of the NRAMP and IL8R genes: identification of a polymorphic repeat in exon 2 of NRAMP.

Authors:  J K White; M A Shaw; C H Barton; D P Cerretti; H Williams; B A Mock; N P Carter; C S Peacock; J M Blackwell
Journal:  Genomics       Date:  1994-11-15       Impact factor: 5.736

6.  Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene.

Authors:  J Liu; T M Fujiwara; N T Buu; F O Sánchez; M Cellier; A J Paradis; D Frappier; E Skamene; P Gros; K Morgan
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

7.  Genomic organization and sequence of the human NRAMP gene: identification and mapping of a promoter region polymorphism.

Authors:  J M Blackwell; C H Barton; J K White; S Searle; A M Baker; H Williams; M A Shaw
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

8.  Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

Authors:  W McGuire; A V Hill; C E Allsopp; B M Greenwood; D Kwiatkowski
Journal:  Nature       Date:  1994-10-06       Impact factor: 49.962

9.  Mutations in katG gene sequences in isoniazid-resistant clinical isolates of Mycobacterium tuberculosis are rare.

Authors:  G S Pretorius; P D van Helden; F Sirgel; K D Eisenach; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

10.  Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression.

Authors:  M Cellier; G Govoni; S Vidal; T Kwan; N Groulx; J Liu; F Sanchez; E Skamene; E Schurr; P Gros
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307
View more
  3 in total

1.  Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family.

Authors:  C M Greenwood; T M Fujiwara; L J Boothroyd; M A Miller; D Frappier; E A Fanning; E Schurr; K Morgan
Journal:  Am J Hum Genet       Date:  2000-07-05       Impact factor: 11.025

2.  The -237C-->T promoter polymorphism of the SLC11A1 gene is associated with a protective effect in relation to inflammatory bowel disease in the South African population.

Authors:  Monique G Zaahl; Trevor A Winter; Louise Warnich; Maritha J Kotze
Journal:  Int J Colorectal Dis       Date:  2005-07-30       Impact factor: 2.571

Review 3.  Immunogenetics of leishmanial and mycobacterial infections: the Belem Family Study.

Authors:  J M Blackwell; G F Black; C S Peacock; E N Miller; D Sibthorpe; D Gnananandha; J J Shaw; F Silveira; Z Lins-Lainson; F Ramos; A Collins; M A Shaw
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.